Radiotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Radiotherapy, including details on cancer treatment, side effects.

Volume 2 (2005), Issue 3 (March)

1. Radiotherapy for uterine cervical cancer: results of the 1995-1997 patterns of care process survey in Japan.
   Jpn J Clin Oncol, 35(3): 139-48. [Abstract] [Full-text]
2. Hyperfractionated radiation therapy for locoregionally advanced nasopharyngeal cancer.
   Jpn J Clin Oncol, 35(3): 116-20. [Abstract] [Full-text]
3. Radiation treatment for medulloblastoma: a review of 64 cases at a single institute.
   Jpn J Clin Oncol, 35(3): 111-5. [Abstract] [Full-text]
4. High-dose radiation-induced meningioma in children - case report and critical review of the literature.
   Zentralbl Neurochir, 66(1): 39-42. [Abstract] [Full-text]
5. Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation.
   Biol Blood Marrow Transplant, 11(3): 223-30. [Abstract] [Full-text]
6. Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma.
   Ophthalmology, 112(3): 505-10. [Abstract] [Full-text]
7. Long-term outcomes after treatment of diffuse in-stent restenosis with rotational atherectomy followed by beta-radiation therapy with a 188Re-MAG3-filled balloon.
   Int J Cardiol, 99(2): 201-5. [Abstract] [Full-text]
8. Recognizing health risks in childhood cancer survivors.
   J Am Acad Nurse Pract, 17(3): 96-103. [Abstract] [Full-text]
9. Radioimmunotherapy and colorectal cancer.
   Br J Surg, 92(3): 264-76. [Abstract] [Full-text]
10. Ultrasound-detected thyroid nodules in radiation-exposed patients: changes over time.
    Thyroid, 15(2): 127-33. [Abstract] [Full-text]
11. Inverse treatment planning based on MRI for HDR prostate brachytherapy.
    Int J Radiat Oncol Biol Phys, 61(4): 1267-75. [Abstract] [Full-text]
12. Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changes.
    Int J Radiat Oncol Biol Phys, 61(4): 1258-66. [Abstract] [Full-text]
13. Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer.
    Int J Radiat Oncol Biol Phys, 61(4): 1251-7. [Abstract] [Full-text]
14. Improved treatment planning for COMS eye plaques.
    Int J Radiat Oncol Biol Phys, 61(4): 1227-42. [Abstract] [Full-text]
15. Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma.
    Int J Radiat Oncol Biol Phys, 61(4): 1062-70. [Abstract] [Full-text]
16. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.
    Int J Radiat Oncol Biol Phys, 61(4): 1019-34. [Abstract] [Full-text]
17. Melphalan pharmacokinetics in children with malignant disease: influence of body weight, renal function, carboplatin therapy and total body irradiation.
    Br J Clin Pharmacol, 59(3): 314-24. [Abstract] [Full-text]
18. A model of DICOM-based electronic patient record in radiation therapy.
    Comput Med Imaging Graph, 29(2): 125-36. [Abstract] [Full-text]
19. Neuropsychological evaluation of late-onset post-radiotherapy encephalopathy: a comparison with vascular dementia.
    J Neurol Sci, 229: 195-200. [Abstract] [Full-text]
20. Advances in vascular brachytherapy over the last 10 years: focus on femoropopliteal applications.
    J Endovasc Ther, 11: II180-91. [Abstract] [Full-text]
21. Teletherapy and radiopharmaceutical therapy of painful bone metastases.
    Semin Nucl Med, 35(2): 152-8. [Abstract] [Full-text]
22. Radioimmunodetection and therapy of breast cancer.
    Semin Nucl Med, 35(2): 143-51. [Abstract] [Full-text]
23. Low cost CCD camera protection against neutron radiation damage.
    J Med Eng Technol, 29(1): 27-32. [Abstract] [Full-text]
24. Current status of radiant whole-body hyperthermia at temperatures >41.5 degrees C and practical guidelines for the treatment of adults. The German 'Interdisciplinary Working Group on Hyperthermia'.
    Int J Hyperthermia, 21(2): 169-83. [Abstract] [Full-text]
25. Enhanced tumour uptake of radiolabelled antibodies by hyperthermia. Part II: Application of the thermal equivalency equation.
    Int J Hyperthermia, 21(1): 13-27. [Abstract] [Full-text]
26. Enhanced tumour uptake of radiolabelled antibodies by hyperthermia: Part I: Timing of injection relative to hyperthermia.
    Int J Hyperthermia, 21(1): 1-11. [Abstract] [Full-text]
27. Production of actinium-225 for alpha particle mediated radioimmunotherapy.
    Appl Radiat Isot, 62(5): 667-79. [Abstract] [Full-text]
28. Hippocampal neurogenesis and PSA-NCAM expression following exposure to 56Fe particles mimics that seen during aging in rats.
    Exp Gerontol, 40(3): 249-54. [Abstract] [Full-text]
29. The use of the source-skin distance measuring bridge indeed reduces skin teleangiectasia after interstitial boost in breast conserving therapy.
    Radiother Oncol, 74(3): 323-30. [Abstract] [Full-text]
30. Clinical impact of the detector size effect in 3D-CRT.
    Radiother Oncol, 74(3): 315-22. [Abstract] [Full-text]
31. Comparison of two dimensional and three dimensional radiotherapy treatment planning in locally advanced non-small cell lung cancer treated with continuous hyperfractionated accelerated radiotherapy weekend less.
    Radiother Oncol, 74(3): 307-14. [Abstract] [Full-text]
32. 3D conformal radiotherapy for gastric cancer--results of a comparative planning study.
    Radiother Oncol, 74(3): 301-6. [Abstract] [Full-text]
33. Quality assurance in radiotherapy: evaluation of errors and incidents recorded over a 10 year period.
    Radiother Oncol, 74(3): 283-91. [Abstract] [Full-text]
34. A randomised comparison of two brachytherapy devices for the treatment of uterine cervical carcinoma.
    Radiother Oncol, 74(3): 247-50. [Abstract] [Full-text]
35. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV.
    Radiother Oncol, 74(3): 235-45. [Abstract] [Full-text]
36. Calculated DNA damage from gadolinium Auger electrons and relation to dose distributions in a head phantom.
    Int J Radiat Biol, 80(11): 933-40. [Abstract] [Full-text]
37. Evolving treatment strategies for inflammatory breast cancer: a population-based survival analysis.
    J Clin Oncol, 23(9): 1941-50. [Abstract] [Full-text]
38. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial.
    J Clin Oncol, 23(9): 1847-58. [Abstract] [Full-text]
39. Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma.
    J Clin Oncol, 23(9): 1839-46. [Abstract] [Full-text]
40. Re-treatment of a lung tumour using a simple intensity-modulated radiotherapy approach.
    Br J Radiol, 78(928): 358-61. [Abstract] [Full-text]
41. Automatic selection of non-coplanar beam directions for three-dimensional conformal radiotherapy.
    Br J Radiol, 78(928): 316-27. [Abstract] [Full-text]
42. Patients' experiences of intracavity brachytherapy treatment for gynaecological cancer.
    Eur J Oncol Nurs, 9(1): 44-55. [Abstract] [Full-text]
43. High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer.
    Eur Urol, 47(4): 441-8. [Abstract] [Full-text]
44. Monte Carlo modeling of gamma cameras for I-131 imaging in targeted radiotherapy.
    Cancer Biother Radiopharm, 20(1): 77-84. [Abstract] [Full-text]
45. The radiobiology of conventional radiotherapy and its application to radionuclide therapy.
    Cancer Biother Radiopharm, 20(1): 47-51. [Abstract] [Full-text]
46. Granulocyte/macrophage colony-stimulating factor and accessory cells modulate radioprotection by purified hematopoietic cells.
    J Exp Med, 201(6): 853-8. [Abstract] [Full-text]
47. Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network.
    Blood, 105(7): 2677-84. [Abstract] [Full-text]
48. The future of radioimmunotherapy: a PET perspective.
    Semin Oncol, 32(1): S63-7. [Abstract] [Full-text]
49. Future trends in radioimmunotherapy.
    Semin Oncol, 32(1): S57-62. [Abstract] [Full-text]
50. Development of 131I-tositumomab.
    Semin Oncol, 32(1): S50-6. [Abstract] [Full-text]
51. 90Y-ibritumomab tiuxetan: rationale for patient selection in the treatment of indolent non-Hodgkin's lymphoma.
    Semin Oncol, 32(1): S44-9. [Abstract] [Full-text]
52. Use of 90Y-ibritumomab tiuxetan in non-Hodgkin's lymphoma.
    Semin Oncol, 32(1): S36-43. [Abstract] [Full-text]
53. Concepts in radioimmunotherapy and immunotherapy: Radioimmunotherapy from a Lym-1 perspective.
    Semin Oncol, 32(1): S27-35. [Abstract] [Full-text]
54. Concepts in radiotherapy and immunotherapy: anti-CD20 mechanisms of action and targets.
    Semin Oncol, 32(1): S19-26. [Abstract] [Full-text]
55. Gamma knife radiosurgery in skull base meningiomas: a possible relationship between somatostatin receptor decrease and early neurological improvement without tumour shrinkage at short-term imaging follow-up.
    Acta Neurochir (Wien), 147(4): 367-74; discussion 374-5. [Abstract] [Full-text]
56. Modified optimal fractionation for poor prognosis malignant gliomas: an elusive search.
    Acta Oncol, 44(2): 105-13. [Abstract] [Full-text]
57. The use of brachytherapy to treat renal artery in-stent restenosis.
    J Interv Cardiol, 18(1): 49-54. [Abstract] [Full-text]
58. Biomedical applications of 10B and 11B NMR.
    NMR Biomed, 18(2): 74-82. [Abstract] [Full-text]
59. Linac radiosurgery as a tool in neurosurgery.
    Neurosurg Rev, 28(2): 79-88; discussion 89-90, 91. [Abstract] [Full-text]
60. Radiation-induced intracranial meningiomas: review of six operated cases.
    Neurosurg Rev, 28(2): 104-14. [Abstract] [Full-text]
61. The effect on erectile function of 103palladium implantation for localized prostate cancer.
    BJU Int, 95(6): 847-50. [Abstract] [Full-text]
62. An improved methodology for modeling neurobehavioral late-effects of radiotherapy in pediatric brain tumors.
    Pediatr Blood Cancer, 44(5): 487-93. [Abstract] [Full-text]
63. Modelling simple helically delivered dose distributions.
    Phys Med Biol, 50(7): 1505-17. [Abstract] [Full-text]
64. Dosimetric study of a new polymer encapsulated palladium-103 seed.
    Phys Med Biol, 50(7): 1493-504. [Abstract] [Full-text]
65. Effect of patient variation on standard- and hypo-fractionated radiotherapy of prostate cancer.
    Phys Med Biol, 50(7): 1483-92. [Abstract] [Full-text]
66. Quantitation of the a priori dosimetric capabilities of spatial points in inverse planning and its significant implication in defining IMRT solution space.
    Phys Med Biol, 50(7): 1469-82. [Abstract] [Full-text]
67. Off-axis chamber response in the depth of photon dose maximum.
    Phys Med Biol, 50(7): 1449-57. [Abstract] [Full-text]
68. Use of an amorphous silicon electronic portal imaging device for multileaf collimator quality control and calibration.
    Phys Med Biol, 50(7): 1377-92. [Abstract] [Full-text]
69. Integrating a MRI scanner with a 6 MV radiotherapy accelerator: dose increase at tissue-air interfaces in a lateral magnetic field due to returning electrons.
    Phys Med Biol, 50(7): 1363-76. [Abstract] [Full-text]
70. Dose verification of single shot gamma knife applications using VIPAR polymer gel and MRI.
    Phys Med Biol, 50(6): 1235-50. [Abstract] [Full-text]
71. Imaging dose management using multi-resolution in CT-guided radiation therapy.
    Phys Med Biol, 50(6): 1205-19. [Abstract] [Full-text]
72. Effects on electron beam penumbra using the photon MLC to reduce bremsstrahlung leakage for an add-on electron MLC.
    Phys Med Biol, 50(6): 1191-203. [Abstract] [Full-text]
73. The effect on IMRT conformality of elastic tissue movement and a practical suggestion for movement compensation via the modified dynamic multileaf collimator (dMLC) technique.
    Phys Med Biol, 50(6): 1163-90. [Abstract] [Full-text]
74. Reducing the number of monitor units in multileaf collimator field segmentation.
    Phys Med Biol, 50(6): 1147-61. [Abstract] [Full-text]
75. Quantitative comparison of suitability of various beams for range monitoring with induced beta+ activity in hadron therapy.
    Phys Med Biol, 50(6): 1131-45. [Abstract] [Full-text]
76. An experimental and Monte Carlo investigation of the energy dependence of alanine/EPR dosimetry: II. Clinical electron beams.
    Phys Med Biol, 50(6): 1119-29. [Abstract] [Full-text]
77. Ir-192 HDR transit dose and radial dose function determination using alanine/EPR dosimetry.
    Phys Med Biol, 50(6): 1109-17. [Abstract] [Full-text]
78. Prediction of radiation-induced normal tissue complications in radiotherapy using functional image data.
    Phys Med Biol, 50(6): 1035-46. [Abstract] [Full-text]
79. Clinical use of a commercial Monte Carlo treatment planning system for electron beams.
    Phys Med Biol, 50(5): 1029-34. [Abstract] [Full-text]
80. 4D Monte Carlo simulation of proton beam scanning: modelling of variations in time and space to study the interplay between scanning pattern and time-dependent patient geometry.
    Phys Med Biol, 50(5): 983-90. [Abstract] [Full-text]
81. Monte Carlo dose calculations for spot scanned proton therapy.
    Phys Med Biol, 50(5): 971-81. [Abstract] [Full-text]
82. Microionization chamber for reference dosimetry in IMRT verification: clinical implications on OAR dosimetric errors.
    Phys Med Biol, 50(5): 959-70. [Abstract] [Full-text]
83. Monte Carlo treatment planning for molecular targeted radiotherapy within the MINERVA system.
    Phys Med Biol, 50(5): 947-58. [Abstract] [Full-text]
84. Adjoint Monte Carlo method for prostate external photon beam treatment planning: an application to 3D patient anatomy.
    Phys Med Biol, 50(5): 923-35. [Abstract] [Full-text]
85. A comparison of Monte Carlo dose calculation denoising techniques.
    Phys Med Biol, 50(5): 909-22. [Abstract] [Full-text]
86. IMRT head and neck treatment planning with a commercially available Monte Carlo based planning system.
    Phys Med Biol, 50(5): 879-90. [Abstract] [Full-text]
87. Dosimetric verification of IMRT treatment planning using Monte Carlo simulations for prostate cancer.
    Phys Med Biol, 50(5): 869-78. [Abstract] [Full-text]
88. Monte Carlo based modulated electron beam treatment planning using a few-leaf electron collimator--feasibility study.
    Phys Med Biol, 50(5): 847-57. [Abstract] [Full-text]
89. The importance of accurate linear accelerator head modelling for IMRT Monte Carlo calculations.
    Phys Med Biol, 50(5): 831-46. [Abstract] [Full-text]
90. Head-and-neck IMRT treatments assessed with a Monte Carlo dose calculation engine.
    Phys Med Biol, 50(5): 817-30. [Abstract] [Full-text]
91. The influence of beam model differences in the comparison of dose calculation algorithms for lung cancer treatment planning.
    Phys Med Biol, 50(5): 801-15. [Abstract] [Full-text]
92. Development of a Monte Carlo model for the Brainlab microMLC.
    Phys Med Biol, 50(5): 787-99. [Abstract] [Full-text]
93. Experimental determination of electron source parameters for accurate Monte Carlo calculation of large field electron therapy.
    Phys Med Biol, 50(5): 779-86. [Abstract] [Full-text]
94. Patient participation in discussing palliative radiotherapy.
    Patient Educ Couns, 57(1): 53-61. [Abstract] [Full-text]
95. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.
    Radiology, 235(1): 208-15. [Abstract] [Full-text]
96. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
    J Clin Oncol, 23(10): 2208-14. [Abstract] [Full-text]

© 2004-2008 Radiotherapy Research Today. All Rights Reserved.